Kaplan Matthew L.

Track

Insider profile

Performance

Overall performance
2.6
Performance over holding periods
2.6
30 days 90 days 120 days
Average return -4% 8.2% 15.1%
Success rate 56% 68% 82%
Transactions
3 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Kaplan Matthew L.'s trades of Nuvectis Pharma Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-11-06 2025-11-05
B Purchase
3,587 +18.7%
12.10
US$2,093,403 		3,587 +18.7% 12.10 US$2,093,403
2022-05-16 2022-05-12
B Purchase
76,935 +22.9%
282.97
US$505,254 		76,935 +22.9% 282.97 US$505,254
2022-05-16 2022-05-12
B Purchase
68,590 -42.2%
36.23
US$1,640,161 		68,590 -42.2% 36.23 US$1,640,161